Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.
Oki S, Sone K, Oda K, Hamamoto R, Ikemura M, Maeda D, Takeuchi M, Tanikawa M, Mori-Uchino M, Nagasaka K, Miyasaka A, Kashiyama T, Ikeda Y, Arimoto T, Kuramoto H, Wada-Hiraike O, Kawana K, Fukayama M, Osuga Y, Fujii T.
Oki S, et al. Among authors: fukayama m.
Oncotarget. 2017 Jun 20;8(25):40402-40411. doi: 10.18632/oncotarget.16316.
Oncotarget. 2017.
PMID: 28418882
Free PMC article.